Top

Published in:

Open Access 01-12-2024 | Acute Lymphoblastic Leukemia | Review

Recent advances on biogenesis, functions and therapeutic potential of long noncoding RNAs in T cell acute lymphoblastic leukemia

Authors: Parminder Kaur, Pankaj Sharma, Prateek Bhatia, Minu Singh

Published in: Discover Oncology | Issue 1/2024

Abstract

T-cell Acute Lymphoblastic Leukemia (T-ALL) is a highly aggressive form of ALL with at least 25% relapse rates. The high relapse rates are often linked to poor prognoses. More detailed studies for novel therapeutic targets for the treatment of T-ALL are required as the genetic and transcriptomic data currently available on T-ALL pathophysiology is insufficient. Long non-coding RNAs are emerging as important players in the regulation of tumour proliferation and metastasis. Studies on various cancers have revealed their potential as biomarkers and therapeutic targets in treatment. This review describes the characterization, biosynthesis, and role of long non-coding RNA in T-ALL and highlights their potential as next generation molecule in development of promising diagnostic, prognostic and/or therapeutic markers.

Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet Lond Engl. 2008;371(9617):1030–43. https://doi.org/10.1016/S0140-6736(08)60457-2.CrossRef

Board, PDQ Pediatric Treatment Editorial, “Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®),” Aug. 2024. https://www.ncbi.nlm.nih.gov/books/NBK65763/

Loganathan T, Doss GPC. Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. Funct Integr Genomics. 2023;23(1):33. https://doi.org/10.1007/s10142-022-00947-4.CrossRefPubMedPubMedCentral

The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74. https://doi.org/10.1038/nature11247.CrossRefPubMedCentral

International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431(7011):931–45. https://doi.org/10.1038/nature03001.CrossRef

Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990;10(1):28–36. https://doi.org/10.1128/mcb.10.1.28-36.1990.CrossRefPubMedPubMedCentral

Mattick JS, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430–47. https://doi.org/10.1038/s41580-022-00566-8.CrossRefPubMedPubMedCentral

Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–69. https://doi.org/10.1534/genetics.112.146704.CrossRefPubMedPubMedCentral

Lee J, Davidow LS, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet. 1999;21(4):400–4. https://doi.org/10.1038/7734.CrossRefPubMed

10.

Marahrens Y, Loring J, Jaenisch R. Role of the Xist Gene in X chromosome choosing. Cell. 1998;92(5):657–64. https://doi.org/10.1016/S0092-8674(00)81133-2.CrossRefPubMed

11.

Alessio E, Bonadio RS, Buson L, Chemello F, Cagnin S. A single cell but many different transcripts: a journey into the world of long non-coding RNAs. Int J Mol Sci. 2020;21(1):302. https://doi.org/10.3390/ijms21010302.CrossRefPubMedPubMedCentral

12.

Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007;8(1):39. https://doi.org/10.1186/1471-2164-8-39.CrossRefPubMedPubMedCentral

13.

Kim D-H, Xi Y, Sung S. Modular function of long noncoding RNA, COLDAIR, in the vernalization response. PLoS Genet [Internet]. 2017;13(7):e1006939. https://doi.org/10.1371/journal.pgen.1006939

14.

Zhang L, Xu H-G, Lu C. A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells. Leuk Lymphoma. 2014;55(6):1373–82. https://doi.org/10.3109/10428194.2013.829574.CrossRefPubMed

15.

Ngoc PCT, et al. Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia. Leukemia. 2018;32(10):2138–51. https://doi.org/10.1038/s41375-018-0110-4.CrossRefPubMedPubMedCentral

16.

Pouyanrad S, Rahgozar S, Ghodousi ES. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. Gene. 2019;692:35–43. https://doi.org/10.1016/j.gene.2019.01.003.CrossRefPubMed

17.

Tianhua Y, Dianqiu L, Xuanhe Z, Zhe Z, Dongmei G. Long non-coding RNA Sox2 overlapping transcript (SOX2OT) promotes multiple myeloma progression via microRNA-143-3p/c-MET axis: Long non-coding RNA Sox2 overlapping transcript (SOX2OT) promotes multiple myeloma progression via microRNA-143-3p/c-MET axis. J Cell Mol Med [Internet]. 2020;24(9):5185–94. https://doi.org/10.1111/jcmm.15171

18.

Maclary E, Hinten M, Harris C, Kalantry S. Long nonoding RNAs in the X-inactivation center. Chromosome Res [Internet]. 2013;21(6–7):601–14. https://doi.org/10.1007/s10577-013-9396-2

19.

Ros G, Pegoraro S, De Angelis P, Sgarra R, Zucchelli S, Gustincich S, et al. HMGA2 antisense long non-coding RNAs as new players in the regulation of HMGA2 expression and pancreatic cancer promotion. Front Oncol [Internet]. 2019;9:1526. https://doi.org/10.3389/fonc.2019.01526

20.

Wang D, Song Q, Zhao T, Wang F, Yu Y, Qi J, et al. Long non-coding RNA MRPS30 divergent transcript can be detected in the cytoplasm of triple-negative breast cancer cells and is targeted by microRNA-130b. Bioengineered [Internet]. 2022;13(3):5954–61. https://doi.org/10.1080/21655979.2022.2031393

21.

Ghildiyal R, Sawant M, Renganathan A, Mahajan K, Kim EH, Luo J, et al. Loss of long noncoding RNA NXTAR in prostate cancer augments androgen receptor expression and enzalutamide resistance. Cancer Res [Internet]. 2022;82(1):155–68. https://doi.org/10.1158/0008-5472.CAN-20-3845

22.

Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med [Internet]. 2015;12(1):1–9. https://doi.org/10.7497/j.issn.2095-3941.2015.0006

23.

Kotake Y, Kitagawa K, Ohhata T, Sakai S, Uchida C, Niida H, et al. Long non-coding RNA, PANDA, contributes to the stabilization of p53 tumor suppressor protein. Anticancer Res. 2016;36(4):1605–11.

24.

Li G, Gao L, Zhao J, Liu D, Li H, Hu M. LncRNA ANRIL/miR-7-5p/TCF4 axis contributes to the progression of T cell acute lymphoblastic leukemia. Cancer Cell Int. 2020;20(1):335. https://doi.org/10.1186/s12935-020-01376-8.CrossRefPubMedPubMedCentral

25.

Tan SH, et al. The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia. Blood. 2019;134(3):239–51. https://doi.org/10.1182/blood.2018874503.CrossRefPubMedPubMedCentral

26.

Martínez-Barriocanal Á, Arango D, Dopeso H. PVT1 long non-coding RNA in gastrointestinal cancer. Front Oncol [Internet]. 2020;10:38. https://doi.org/10.3389/fonc.2020.00038

27.

Schlackow M, Nojima T, Gomes T, Dhir A, Carmo-Fonseca M, Proudfoot NJ. Distinctive patterns of transcription and RNA processing for human lincRNAs. Mol Cell. 2017;65(1):25–38. https://doi.org/10.1016/j.molcel.2016.11.029.CrossRefPubMedPubMedCentral

28.

Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2):632. https://doi.org/10.3390/ijms22020632.CrossRefPubMedPubMedCentral

29.

Zuckerman B, Ron M, Mikl M, Segal E, Ulitsky I. Gene architecture and sequence composition underpin selective dependency of nuclear export of long RNAs on NXF1 and the TREX complex. Mol Cell. 2020;79(2):251-267.e6. https://doi.org/10.1016/j.molcel.2020.05.013.CrossRefPubMed

30.

Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 2022;23(6):389–406. https://doi.org/10.1038/s41580-021-00447-6.CrossRefPubMed

31.

Hirano T, Yoshikawa R, Harada H, Harada Y, Ishida A, Yamazaki T. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression. Mol Cancer. 2015;14(1):90. https://doi.org/10.1186/s12943-015-0364-7.CrossRefPubMedPubMedCentral

32.

Pan J-Q, Zhang Y-Q, Wang J-H, Xu P, Wang W. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia. Int J Mol Med. 2017;39(3):663–71. https://doi.org/10.3892/ijmm.2017.2888.CrossRefPubMedPubMedCentral

33.

Wang Y, Li Y, Song H-Q, Sun G-W. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia. Eur Rev Med Pharmacol Sci. 2018;22(21):7364–70. https://doi.org/10.26355/eurrev_201811_16274.CrossRefPubMed

34.

Li J, Sun C-K. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia. Eur Rev Med Pharmacol Sci. 2018;22(11):3342–7. https://doi.org/10.26355/eurrev_201806_15154.CrossRefPubMed

35.

Ma L, Kuai W-X, Sun X-Z, Lu X-C, Yuan Y-F. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(22):7867–76. https://doi.org/10.26355/eurrev_201811_16412.CrossRefPubMed

36.

Papaioannou D, et al. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nat Commun. 2019;10(1):5351. https://doi.org/10.1038/s41467-019-13259-2.CrossRefPubMedPubMedCentral

37.

Zhu G, et al. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia. Nat Commun. 2021;12(1):1956. https://doi.org/10.1038/s41467-021-22095-2.CrossRefPubMedPubMedCentral

38.

Fernando TR, et al. LncRNA expression discriminates karyotype and predicts survival in B-lymphoblastic leukemia. Mol Cancer Res. 2015;13(5):839–51. https://doi.org/10.1158/1541-7786.MCR-15-0006-T.CrossRefPubMedPubMedCentral

39.

Cuadros M, et al. Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia. Blood Cancer J. 2019;9(12):93. https://doi.org/10.1038/s41408-019-0258-9.CrossRefPubMedPubMedCentral

40.

de Chagas PF, et al. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2021;43(1):28–34. https://doi.org/10.1016/j.htct.2019.12.003.CrossRefPubMed

41.

Bárcenas-López DA, et al. Transcriptome analysis identifies LINC00152 as a biomarker of early relapse and mortality in acute lymphoblastic leukemia. Genes. 2020;11(3):302. https://doi.org/10.3390/genes11030302.CrossRefPubMedPubMedCentral

42.

Sharma P, Kaur P, Bhatia P, Trehan A, Sreedharanunni S, Singh M. Novel lncRNAs LINC01221, RP11–472G21.2 and CRNDE are markers of differential expression in pediatric patients with T cell acute lymphoblastic leukemia. Cancer Cell Int. 2024;24(1):65. https://doi.org/10.1186/s12935-024-03255-y.CrossRefPubMedPubMedCentral

43.

Ferrandol AA. The role of NOTCH1 signaling in T-ALL. Hematology. 2009;2009:353–61.CrossRef

44.

Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129(9):1113–23. https://doi.org/10.1182/blood-2016-10-706465.CrossRefPubMed

45.

El-Khazragy N, et al. Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia. Immunobiology. 2021;226(6): 152149. https://doi.org/10.1016/j.imbio.2021.152149.CrossRefPubMed

46.

Li J, et al. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25. Mol Immunol. 2021;140:267–75. https://doi.org/10.1016/j.molimm.2021.10.016.CrossRefPubMed

47.

Li S, Guo W, Geng H, Wang C, Yang S, Xu X. LINC00511 exacerbated T-cell acute lymphoblastic leukemia via miR-195-5p/LRRK1 axis. Biosci Rep. 2020;40(5):BSR20193631. https://doi.org/10.1042/BSR20193631.CrossRefPubMedPubMedCentral

48.

Liu Q, et al. The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia. J Exp Clin Cancer Res. 2019;38(1):199. https://doi.org/10.1186/s13046-019-1208-x.CrossRefPubMedPubMedCentral

49.

Li X, Song F, Sun H. Long non-coding RNA AWPPH interacts with ROCK2 and regulates the proliferation and apoptosis of cancer cells in pediatric T-cell acute lymphoblastic leukemia. Oncol Lett. 2020;20(5):1–1. https://doi.org/10.3892/ol.2020.12102.CrossRef

50.

Chen L, et al. LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335–3p/TRAF5 axis. Anticancer Drugs. 2020. https://doi.org/10.1097/CAD.0000000000001001.CrossRefPubMedPubMedCentral

51.

Yang J, Yang Y. Long noncoding RNA endogenous bornavirus-like nucleoprotein acts as an oncogene by regulating microRNA-655-3p expression in T-cell acute lymphoblastic leukemia. Bioengineered. 2022;13(3):6409–19. https://doi.org/10.1080/21655979.2022.2044249.CrossRefPubMedPubMedCentral

52.

Patra N, et al. Clinico-hematological profile and copy number abnormalities in a cohort of STIL-TAL1 and NUP214-ABL1 positive pediatric T-cell acute lymphoblastic leukemia. Indian J Hematol Blood Transfus. 2021;37(4):555–62. https://doi.org/10.1007/s12288-020-01394-6.CrossRefPubMedPubMedCentral

53.

Tan TK, Zhang C, Sanda T. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia. Int J Hematol. 2019;109(1):5–17. https://doi.org/10.1007/s12185-018-2518-z.CrossRefPubMed

54.

Vagapova ER, Spirin PV, Lebedev TD, Prassolov VS. The role of TAL1 in hematopoiesis and leukemogenesis. Acta Naturae. 2018;10(1):15–23.CrossRefPubMedPubMedCentral

55.

Porcher C, Chagraoui H, Kristiansen MS. SCL/TAL1: a multifaceted regulator from blood development to disease. Blood. 2017;129(15):2051–60. https://doi.org/10.1182/blood-2016-12-754051.CrossRefPubMed

56.

Sanda T, Leong WZ. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia. Exp Hematol. 2017;53:7–15. https://doi.org/10.1016/j.exphem.2017.06.001.CrossRefPubMed

57.

Bhatia P, et al. PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: data from a tertiary care centre in India. Blood Cells Mol Dis. 2020;82: 102419. https://doi.org/10.1016/j.bcmd.2020.102419.CrossRefPubMed

58.

González-García S, et al. CSL–MAML-dependent Notch1 signaling controls T lineage–specific IL-7Rα gene expression in early human thymopoiesis and leukemia. J Exp Med. 2009;206(4):779–91. https://doi.org/10.1084/jem.20081922.CrossRefPubMedPubMedCentral

59.

Yousefi H, Purrahman D, Jamshidi M, Lak E, Keikhaei B, Mahmoudian-Sani M-R. Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia. Clin Transl Oncol. 2022;24(11):2081–9. https://doi.org/10.1007/s12094-022-02886-9.CrossRefPubMed

60.

Medyouf H, et al. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med. 2011;208(9):1809–22. https://doi.org/10.1084/jem.20110121.CrossRefPubMedPubMedCentral

61.

Trimarchi T, et al. Genome-wide mapping and characterization of notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158(3):593–606. https://doi.org/10.1016/j.cell.2014.05.049.CrossRefPubMedPubMedCentral

62.

Wang Y, Wu P, Lin R, Rong L, Xue Y, Fang Y. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015;5(1):13749. https://doi.org/10.1038/srep13749.CrossRefPubMedPubMedCentral

63.

Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci. 1975;72(9):3666–70. https://doi.org/10.1073/pnas.72.9.3666.CrossRefPubMedPubMedCentral

64.

Li H, Zhu H, Xu C, Yuan J. Cleavage of BID by Caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94(4):491–501. https://doi.org/10.1016/S0092-8674(00)81590-1.CrossRefPubMed

65.

Nagata S. Apoptosis by death factor. Cell. 1997;88(3):355–65. https://doi.org/10.1016/S0092-8674(00)81874-7.CrossRefPubMed

66.

Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. https://doi.org/10.1080/01926230701320337.CrossRefPubMedPubMedCentral

67.

Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull. 2017;7(3):339–48. https://doi.org/10.15171/apb.2017.041.CrossRefPubMedPubMedCentral

68.

Cheng J, Chen J, Zhang X, Mei H, Wang F, Cai Z. Overexpression of CRNDE promotes the progression of bladder cancer. Biomed Pharmacother. 2018;99:638–44. https://doi.org/10.1016/j.biopha.2017.12.055.CrossRefPubMed

69.

Ding J, et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death Dis. 2017;8(8):e2997–e2997. https://doi.org/10.1038/cddis.2017.328.CrossRefPubMedPubMedCentral

70.

Huan J, Xing L, Lin Q, Xui H, Qin X. Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer. Am J Transl Res. 2017;9(4):1977–89.PubMedPubMedCentral

71.

Lu Y, et al. CRNDE: an oncogenic long non-coding RNA in cancers. Cancer Cell Int. 2020;20(1):162. https://doi.org/10.1186/s12935-020-01246-3.CrossRefPubMedPubMedCentral

72.

Meng Y, Li Q, Li L, Ma R. The long non-coding RNA CRNDE promotes cervical cancer cell growth and metastasis. Biol Chem. 2017;399(1):93–100. https://doi.org/10.1515/hsz-2017-0199.CrossRefPubMed

73.

Jiang H, et al. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways. Cell Death Dis. 2017;8(6):e2862–e2862. https://doi.org/10.1038/cddis.2017.258.CrossRefPubMedPubMedCentral

74.

Li Z, Tang Y, Xing W, Dong W, Wang Z. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. Exp Mol Pathol. 2018;104(1):19–25. https://doi.org/10.1016/j.yexmp.2017.12.002.CrossRefPubMed

75.

Liu X, Xiong H, Huang J, Qi K, Xu J. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma. Clin Exp Pharmacol Physiol. 2017;44(8):895–902. https://doi.org/10.1111/1440-1681.12780.CrossRefPubMed

76.

Shehata AMF, et al. LncRNA CRNDE is downregulated and associated with poor prognostic markers in chronic lymphocytic leukemia. Int J Lab Hematol. 2023. https://doi.org/10.1111/ijlh.14186.CrossRefPubMed

77.

Liu C, et al. LncRNA RP11–620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis. Biol Direct. 2023;18(1):15. https://doi.org/10.1186/s13062-023-00370-0.CrossRefPubMedPubMedCentral

78.

Groskopf J, et al. APTIMA pca3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem. 2006;52(6):1089–95. https://doi.org/10.1373/clinchem.2005.063289.CrossRefPubMed

79.

Adewunmi O, Shen Y, Zhang XH-F, Rosen JM. Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple negative breast cancer. Cancer Immunol Res. 2023. https://doi.org/10.1158/2326-6066.CIR-23-0045.CrossRefPubMedPubMedCentral

80.

Wu S, Liu L, Xu H, Zhu Q, Tan M. The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer. Cancer Biol Ther. 2023;24(1):2249174. https://doi.org/10.1080/15384047.2023.2249174.CrossRefPubMedPubMedCentral

81.

Donlic A, Morgan BS, Xu JL, Liu A, Roble C, Hargrove AE. Discovery of small molecule ligands for MALAT1 by tuning an RNA-binding scaffold. Angew Chem. 2018;130(40):13426–31. https://doi.org/10.1002/ange.201808823.CrossRef

82.

Ostini A, Mourtada-Maarabouni M. Investigation into the role of long-non-coding RNA MIAT in leukemia. Non-Coding RNA. 2023;9(4):47. https://doi.org/10.3390/ncrna9040047.CrossRefPubMedPubMedCentral

83.

Yuan X, Wang J, Tang X, Li Y, Xia P, Gao X. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles. J Transl Med. 2015;13(1):24. https://doi.org/10.1186/s12967-015-0383-6.CrossRefPubMedPubMedCentral

Title: Recent advances on biogenesis, functions and therapeutic potential of long noncoding RNAs in T cell acute lymphoblastic leukemia
Authors: Parminder Kaur
Pankaj Sharma
Prateek Bhatia
Minu Singh
Publication date: 01-12-2024
Publisher: Springer US
Keyword: Acute Lymphoblastic Leukemia
Published in: Discover Oncology / Issue 1/2024
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI: https://doi.org/10.1007/s12672-024-01618-5

Establish TIIC signature score based the machine learning fusion in bladder cancer

Open Access
Bladder Cancer
Analysis

DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family

Open Access
Biomarkers
Research

The endoplasmic reticulum stress-related genes and molecular typing predicts prognosis and reveals characterization of tumor immune microenvironment in lung squamous cell carcinoma

Open Access
Research

AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer

Open Access
Colorectal Cancer
Research

Identifying causal relationships between 35 blood and urine biomarkers and urologic cancers: MR-meta combined with Bayesian colocalization Mendelian randomization analysis

Open Access
Biomarkers
Analysis

The value of 68Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis

Open Access
Prostate Cancer
Research

Keynote webinar | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote series | Spotlight on menopause

Springer Medicine

Recent advances on biogenesis, functions and therapeutic potential of long noncoding RNAs in T cell acute lymphoblastic leukemia

Abstract

Other articles of this Issue 1/2024

Establish TIIC signature score based the machine learning fusion in bladder cancer

DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family

The endoplasmic reticulum stress-related genes and molecular typing predicts prognosis and reveals characterization of tumor immune microenvironment in lung squamous cell carcinoma

AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer

Identifying causal relationships between 35 blood and urine biomarkers and urologic cancers: MR-meta combined with Bayesian colocalization Mendelian randomization analysis

The value of 68Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis

Keynote webinar | Spotlight on menopause

Keynote webinar | Spotlight on adolescent vaping

Keynote webinar | Spotlight on modern management of frailty

A quick guide to ECGs

At a glance: The STEP trials

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Please log in to get access to this content